Boston Scientific to Buy Baylis Medical for $1.75 Billion
October 06 2021 - 7:50AM
Dow Jones News
By Colin Kellaher
Boston Scientific Corp. on Wednesday said it agreed to buy
privately held Baylis Medical Co. for $1.75 billion in cash in a
deal that bolsters its position in left-heart procedures.
The Marlborough, Mass., maker of medical devices said Baylis,
based in Mississauga, Ontario, has about 800 employees and expects
to generate sales approaching $200 million next year.
Boston Scientific said the deal, which it expects to complete in
the first quarter of 2022, adds the radiofrequency NRG and
VersaCross transseptal platforms, along with a family of
guidewires, sheaths and dilators used to support left heart
access.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 06, 2021 07:35 ET (11:35 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2023 to Apr 2024
